Form 4 Nuvectis Pharma Inc For: 1 July
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Nuvectis Pharma Inc (NVCT)
Nuvectis Pharma Inc stock price live, this page displays NASDAQ NVCT stock exchange data. View the NVCT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Nuvectis Pharma Inc real time stock price chart below.
What Is the Nuvectis Pharma Inc Stock Price Today?
The Nuvectis Pharma Inc stock price today is 18.30.
What Is the Stock Symbol for Nuvectis Pharma Inc?
The stock symbol for Nuvectis Pharma Inc is "NVCT."
What Stock Exchange Does Nuvectis Pharma Inc Trade On?
Nuvectis Pharma Inc is listed and trades on the NASDAQ stock exchange.
Is Nuvectis Pharma Inc a Good Stock to Buy?
Determining whether Nuvectis Pharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NVCT quote. (ISIN: US67080T1088)
What Is the Nuvectis Pharma Inc Stock Price Today?
The Nuvectis Pharma Inc stock price today is 18.30.
What Is the Stock Symbol for Nuvectis Pharma Inc?
The stock symbol for Nuvectis Pharma Inc is "NVCT."
What Stock Exchange Does Nuvectis Pharma Inc Trade On?
Nuvectis Pharma Inc is listed and trades on the NASDAQ stock exchange.
Is Nuvectis Pharma Inc a Good Stock to Buy?
Determining whether Nuvectis Pharma Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the NVCT quote. (ISIN: US67080T1088)
18.30
-0.69(-3.63%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
18.21
19.01
52 wk Range
5.55
29.28
NVCT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
18.2119.01
52 wk Range
5.5529.28
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
NVCT Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Neutral
Analysts Sentiment
Strong Buy
Price Target
31.80
Upside
+73.77%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock price often moves in the opposite direction of the market
- Form 4 Nuvectis Pharma Inc For: 1 July
- Investing.com
- Form 424B5 Nuvectis Pharma Inc For: 30 June
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Analyst Ratings
5 Buy
0 Hold
0 Sell
Ratings:
5 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 31.80
(+73.77% Upside)
Earnings
Latest Release
May 05, 2026
EPS / Forecast
-0.26 / -0.31
Revenue / Forecast
-- / --
Compare NVCT to Peers and Sector
Metrics to compare | NVCT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipNVCTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −20.2x | −4.2x | −0.4x | |
PEG Ratio | 1.25 | −0.11 | 0.00 | |
Price/Book | 42.1x | 2.7x | 2.6x | |
Price / LTM Sales | - | 13.5x | 3.0x | |
Upside (Analyst Target) | 73.8% | 101.4% | 51.9% | |
Fair Value Upside | Unlock | 15.1% | 9.1% | Unlock |
Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. The company is developing NXP900, a small molecule drug candidate, which is in Phase 1b clinical trial that inhibits the proto-oncogene c-Src and YES1 kinases for treating solid tumors. The company was formerly known as Centry Pharma, Inc. and changed its name to Nuvectis Pharma, Inc. in July 2021. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Nuvectis Pharma (NVCT) Stock Price Today?
The Nuvectis Pharma stock price today is 18.30 USD.
What Stock Exchange Does Nuvectis Pharma Trade On?
Nuvectis Pharma is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Nuvectis Pharma?
The stock symbol for Nuvectis Pharma is "NVCT."
What Is the Nuvectis Pharma Market Cap?
As of today, Nuvectis Pharma market cap is 598.67M USD.
What Is Nuvectis Pharma's Earnings Per Share (TTM)?
The Nuvectis Pharma EPS (TTM) is -1.30.
When Is the Next Nuvectis Pharma Earnings Date?
Nuvectis Pharma will release its next earnings report on Aug 11, 2026.
From a Technical Analysis Perspective, Is NVCT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Neutral.
How Many Times Has Nuvectis Pharma Stock Split?
Nuvectis Pharma has split 0 times.
How Many Employees Does Nuvectis Pharma Have?
Nuvectis Pharma has 12 employees.
What is the current trading status of Nuvectis Pharma (NVCT)?
As of Jul 10, 2026, Nuvectis Pharma (NVCT) is trading at a price of 18.30 USD, with a previous close of 18.99 USD. The stock has fluctuated within a day range of 18.21 USD to 19.01 USD, while its 52-week range spans from 5.55 USD to 29.28 USD.
What Is Nuvectis Pharma (NVCT) Price Target According to Analysts?
The average 12-month price target for Nuvectis Pharma is 31.80 USD, with a high estimate of 39 USD and a low estimate of 22 USD. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +73.77% Upside potential.
What Is the NVCT After Hours Price?
NVCT's last after hours stock price is 18.94 USD, the stock has decreased by -0.05, or -0.26%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.